Global Solid Tumors Drugs Market

Bharat Book Bureau provides the report; on “Global Solid Tumors Drugs Market”. This report drugs may increase the competition in the market, eventually reducing the price of key drugs. https://www.bharatbook.com/healthcare-market-research-reports-767539/solid-tumors-drugs-global.html

Bharatbook.com announces a report on “Global Solid Tumors Drugs Market”. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Commenting on the report, an analyst from Research team said: “A trend which is helping to boost market growth is the emergence of targeted and combination therapies. Targeted and combination therapies are being increasingly developed to treat solid tumors. Targeted therapies, which exploit the surface markers or properties of diseased or infected cells, cause fewer adverse effects than conventional non-targeted therapies. For example, in 20% of the cases, breast cancer is associated with the over expression of HER2, wherein drugs such as Kadcyla and Herceptin are administered as mono therapies or in combination. Targeting multiple pathways is known to reduce the risk of developing treatment-resistant disorders. Thus, combination therapies, which target distinct mechanisms, are highly efficacious in treating solid tumors.”

According to the report, a key growth driver which is helping to boost market growth is the exposure to risk factors. Exposure to risk factors for solid tumors and the decrease in practices that reduce this risk are expected to increase the incidence of solid tumors. Solid tumors are associated with modifiable risk factors such as alcohol consumption, physical inactivity, weight gain, and obesity.

For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer. The consumption of three to six glasses of alcoholic drinks per week can increase the risk of developing the disease by 15%. Also, women...